September 26, 2017 - September 27, 2017
Washington DC
Panelist: Roger Longman
Real Endpoints LLC
As the cost of health care continues to rise, understanding, obtaining, and paying for value has become an increasingly critical issue. In recent years, several organizations have put forward new approaches to evaluate and assess the value of medical interventions. However, these existing frameworks are largely built on a traditional definition of value that does not adequately incorporate and reflect the patient perspective. This is why FasterCures and Avalere Health partnered to develop the first patient-centered value framework.
view event >
April 27, 2025 - May 1, 2025
Las Vegas, NV
The Real Endpoints team will be on the ground for Asembia’s AXS25 Summit April 27 – May 1 to discuss market access, pricing and contracting, and patient support services.
April 28, 2024 - May 2, 2024
Las Vegas, NV
The Real Endpoints team will be on the ground for Asembia’s AXS24 Summit April 28 – May 2 to discuss market access, pricing and contracting, and patient support services.
April 15, 2024 - April 17, 2024
Cambridge, UK
Jeff Berkowtiz, CEO
The ABI conference is an annual invitation-only gathering of industry leaders, scientists and inventors, and innovators that alternates between Cambridge UK and Cambridge US. On April 16, CEO Jeff Berkowitz will present a talk, “Paying for Innovation.”
April 15, 2024 - April 18, 2024
New Orleans, LA
Rob O'Brien, SVP Specialty
On April 17, Rob O’Brien will join payers and thought leaders at this year’s annual AMCP meeting to discuss prescription digital therapeutics and how to prepare for coverage.
January 7, 2024
San Francisco, CA
Jeff Berkowitz, CEO
Real Endpoints
Real Endpoints CEO, Jeff Berkowitz to be participating in the Sachs NIF at JPM24. Given the level of innovation in CNS, it’s a timely discussion.
November 17, 2023
Chicago, IL
Rob O'Brien, SVP Specialty
A day-long meeting in Chicago focused on healthcare and pharmaceutical marketplace trends, including a review of the specialty pipeline, implications of the IRA, and potential pharmaceutical disruptions. Rob O’Brien, SVP of Specialty, presenting.
Manager
Payer & Channel Insights, Marketing Analytics & Business Insights